Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Clinical trial NCT07654361 · RECRUITING

Trial details

NCT number: NCT07654361
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Obesity Overweight Chronic Weight Management

Start date: 2026-07-13
Primary completion: 2028-09-01
Enrollment: 3600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.